Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage

Journal of Dermatological Science

Volumn 56, Issue 3, 2009, Pages 154-162

  Lee, Margaret S ^a   Yaar, Mina ^a   Eller, Mark S ^a   Rünger, Thomas M ^a   Gao, Ying ^a   Gilchrest, Barbara A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DNA damage responses; Oxidative stress; Senescence; T oligos

Indexed keywords

ATM PROTEIN; CHECKPOINT KINASE 2; COPPER ZINC SUPEROXIDE DISMUTASE; DIPHENYLIODONIUM SALT; DNA; MANGANESE SUPEROXIDE DISMUTASE; OLIGONUCLEOTIDE; PROTEIN P53; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; CELL AGING; CELL CYCLE ARREST; CELL METABOLISM; CELL PROTECTION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TELOMERE; WESTERN BLOTTING; WILD TYPE;

CELL CYCLE PROTEINS; CELL LINE; DNA; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; FIBROBLASTS; HISTONES; HUMANS; NADPH OXIDASE; OLIGONUCLEOTIDES; OXIDATIVE STRESS; PROTEIN-SERINE-THREONINE KINASES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TELOMERE; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 70449519431     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2009.08.008     Document Type: Article

References (115)

1. Moyzis R.K., Buckingham J.M., Cram L.S., Dani M., Deaven L.L., Jones M.D., et al. A highly conserved repetitive DNA sequence (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85 (1988) 6622-6626
2. AS I.J., and Greider C.W. Short telomeres induce a DNA damage response in Saccharomyces cerevisiae. Mol Biol Cell 14 (2003) 987-1001
3. Shay J.W., and Wright W.E. Telomeres are double-strand DNA breaks hidden from DNA damage responses. Mol Cell 14 (2004) 420-421
4. Takai H., Smogorzewska A., and de Lange T. DNA damage foci at dysfunctional telomeres. Curr Biol 13 (2003) 1549-1556
5. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., et al. Extension of life-span by introduction of telomerase into normal human cells. Science (New York NY) 279 (1998) 349-352
6. Hasty P., Campisi J., Hoeijmakers J., van Steeg H., and Vijg J. Aging and genome maintenance: lessons from the mouse?. Science (New York NY) 299 (2003) 1355-1359
7. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., Bianchi A., Moss H., et al. Mammalian telomeres end in a large duplex loop. Cell 97 (1999) 503-514
8. Karlseder J., Broccoli D., Dai Y., Hardy S., and de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science (New York NY) 283 (1999) 1321-1325
9. van Steensel B., Smogorzewska A., and de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 92 (1998) 401-413
10. Eller M.S., Puri N., Hadshiew I.M., Venna S.S., and Gilchrest B.A. Induction of apoptosis by telomere 3′ overhang-specific DNA. Exp Cell Res 276 (2002) 185-193
11. Ohashi N., Yaar M., Eller M.S., Truzzi F., and Gilchrest B.A. Features that determine telomere homolog oligonucleotide-induced therapeutic DNA damage-like responses in cancer cells. J Cell Physiol 210 (2007) 582-595
12. Yaar M., Eller M.S., Panova I., Kubera J., Wee L.H., Cowan K.H., et al. Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells. Breast Cancer Res 9 (2007) R13
13. Eller M.S., Li G.Z., Firoozabadi R., Puri N., and Gilchrest B.A. Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3′ overhang specific DNA. FASEB J 17 (2003) 152-162
14. Li G.Z., Eller M.S., Firoozabadi R., and Gilchrest B.A. Evidence that exposure of the telomere 3′ overhang sequence induces senescence. Proc Natl Acad Sci USA 100 (2003) 527-531
15. Li G.Z., Eller M.S., Hanna K., and Gilchrest B.A. Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides. Exp Cell Res 301 (2004) 189-200
16. Puri N., Eller M.S., Byers H.R., Dykstra S., Kubera J., and Gilchrest B.A. Telomere-based DNA damage responses: a new approach to melanoma. FASEB J 18 (2004) 1373-1381
17. Eller M.S., Maeda T., Magnoni C., Atwal D., and Gilchrest B.A. Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response. Proc Natl Acad Sci USA 94 (1997) 12627-12632
18. Goukassian D.A., Eller M.S., Yaar M., and Gilchrest B.A. Thymidine dinucleotide mimics the effect of solar simulated irradiation on p53 and p53-regulated proteins. J Invest Dermatol 112 (1999) 25-31
19. Eller M.S., Liao X., Liu S., Hanna K., Backvall H., Opresko P.L., et al. A role for WRN in telomere-based DNA damage responses. Proc Natl Acad Sci USA 103 (2006) 15073-15078
20. Gilchrest B.A. Using DNA damage responses to prevent and treat skin cancers. J Dermatol 31 (2004) 862-877
21. Gray M.D., Shen J.C., Kamath-Loeb A.S., Blank A., Sopher B.L., Martin G.M., et al. The Werner syndrome protein is a DNA helicase. Nat Genet 17 (1997) 100-103
22. Yu C.E., Oshima J., Fu Y.H., Wijsman E.M., Hisama F., Alisch R., et al. Positional cloning of the Werner's syndrome gene. Science (New York, NY) 272 (1996) 258-262
23. Blander G., Kipnis J., Leal J.F., Yu C.E., Schellenberg G.D., and Oren M. Physical and functional interaction between p53 and the Werner's syndrome protein. J Biol Chem 274 (1999) 29463-29469
24. Spillare E.A., Robles A.I., Wang X.W., Shen J.C., Yu C.E., Schellenberg G.D., et al. p53-mediated apoptosis is attenuated in Werner syndrome cells. Genes Dev 13 (1999) 1355-1360
25. Wang X.W., Tseng A., Ellis N.A., Spillare E.A., Linke S.P., Robles A.I., et al. Functional interaction of p53 and BLM DNA helicase in apoptosis. J Biol Chem 276 (2001) 32948-32955
26. Franco R., Schoneveld O., Georgakilas A.G., and Panayiotidis M.I. Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett 266 (2008) 6-11
27. Mates J.M., Segura J.A., Alonso F.J., and Marquez J. Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis. Arch Toxicol 82 (2008) 273-299
28. Camhi S.L., Lee P., and Choi A.M. The oxidative stress response vol. 3 (1995), New horizons, Baltimore, MD p. 170-82
29. Martindale J.L., and Holbrook N.J. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192 (2002) 1-15
30. Thannickal V.J., and Fanburg B.L. Reactive oxygen species in cell signaling. Am J Physiol 279 (2000) L1005-1028
31. Karihtala P., and Soini Y. Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. Apmis 115 (2007) 81-103
32. Mates J.M., and Sanchez-Jimenez F. Antioxidant enzymes and their implications in pathophysiologic processes. Front Biosci 4 (1999) D339-345
33. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39 (2007) 44-84
34. Brigelius-Flohe R. Glutathione peroxidases and redox-regulated transcription factors. Biol Chem 387 (2006) 1329-1335
35. Lei X.G., Cheng W.H., and McClung J.P. Metabolic regulation and function of glutathione peroxidase-1. Annu Rev Nutr 27 (2007) 41-61
36. Fernandes A.P., and Holmgren A. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal 6 (2004) 63-74
37. Hirt R.P., Muller S., Embley T.M., and Coombs G.H. The diversity and evolution of thioredoxin reductase: new perspectives. Trends Parasitol 18 (2002) 302-308
38. Culotta V.C., Yang M., and O'Halloran T.V. Activation of superoxide dismutases: putting the metal to the pedal. Biochim Biophys Acta 1763 (2006) 747-758
39. Johnson F., and Giulivi C. Superoxide dismutases and their impact upon human health. Mol Aspects Med 26 (2005) 340-352
40. Zelko I.N., Mariani T.J., and Folz R.J. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33 (2002) 337-349
41. Kirkman H.N., and Gaetani G.F. Mammalian catalase: a venerable enzyme with new mysteries. Trends Biochem Sci 32 (2007) 44-50
42. Leccia M.T., Yaar M., Allen N., Gleason M., and Gilchrest B.A. Solar simulated irradiation modulates gene expression and activity of antioxidant enzymes in cultured human dermal fibroblasts. Exp Dermatol 10 (2001) 272-279
43. Toussaint O., Medrano E.E., and von Zglinicki T. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp Gerontol 35 (2000) 927-945
44. Hayflick L., and Moorhead P.S. The serial cultivation of human diploid cell strains. Exp Cell Res 25 (1961) 585-621
45. Stewart S.A., and Weinberg R.A. Telomerase and human tumorigenesis. Semin Cancer Biol 10 (2000) 399-406
46. Sugrue M.M., Shin D.Y., Lee S.W., and Aaronson S.A. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc Natl Acad Sci USA 94 (1997) 9648-9653
47. Serrano M., Lin A.W., McCurrach M.E., Beach D., and Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88 (1997) 593-602
48. Zhu J., Woods D., McMahon M., and Bishop J.M. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev 12 (1998) 2997-3007
49. Helbock H.J., Beckman K.B., Shigenaga M.K., Walter P.B., Woodall A.A., Yeo H.C., et al. DNA oxidation matters: the HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine. Proc Natl Acad Sci USA 95 (1998) 288-293
50. von Zglinicki T. Role of oxidative stress in telomere length regulation and replicative senescence. Ann NY Acad Sci 908 (2000) 99-110
51. Freeman B.A., and Crapo J.D. Biology of disease: free radicals and tissue injury. Lab Invest: J Tech Meth Pathol 47 (1982) 412-426
52. Babior B.M. NADPH oxidase: an update. Blood 93 (1999) 1464-1476
53. Babior B.M., Lambeth J.D., and Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 397 (2002) 342-344
54. Bokoch G.M., and Knaus U.G. NADPH oxidases: not just for leukocytes anymore!. Trends Biochem Sci 28 (2003) 502-508
55. 2 production in lung fibroblasts stimulated by transforming growth factor beta1. J Biol Chem 273 (1998) 23611-23615
56. Thannickal V.J. The paradox of reactive oxygen species: injury, signaling, or both?. Am J Physiol 284 (2003) L24-25
57. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82 (2002) 47-95
58. Bae Y.S., Kang S.W., Seo M.S., Baines I.C., Tekle E., Chock P.B., et al. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272 (1997) 217-221
59. 2 for platelet-derived growth factor signal transduction. Science (New York, NY) 270 (1995) 296-299
60. Davies K.J. The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life 48 (1999) 41-47
61. Pryor W.A., Houk K.N., Foote C.S., Fukuto J.M., Ignarro L.J., Squadrito G.L., et al. Free radical biology and medicine: it's a gas, man!. Am J Physiol Regul Integr Comp Physiol 291 (2006) R491-511
62. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., and Vogelstein B. A model for p53-induced apoptosis. Nature 389 (1997) 300-305
63. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92 (1995) 9363-9367
64. Plisko A., and Gilchrest B.A. Growth factor responsiveness of cultured human fibroblasts declines with age. J Gerontol 38 (1983) 513-518
65. Gottlieb E., Haffner R., von Ruden T., Wagner E.F., and Oren M. Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J 13 (1994) 1368-1374
66. Shaulian E., Zauberman A., Ginsberg D., and Oren M. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol Cell Biol 12 (1992) 5581-5592
67. Rheinwald J.G., Hahn W.C., Ramsey M.R., Wu J.Y., Guo Z., Tsao H., et al. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol Cell Biol 22 (2002) 5157-5172
68. Eller M.S., Yaar M., and Gilchrest B.A. DNA damage and melanogenesis. Nature 372 (1994) 413-414
69. Marwaha V., Chen Y.H., Helms E., Arad S., Inoue H., Bord E., et al. T-oligo treatment decreases constitutive and UVB-induced COX-2 levels through p53- and NFkappaB-dependent repression of the COX-2 promoter. J Biol Chem 280 (2005) 32379-32388
70. Narayanan P.K., Goodwin E.H., and Lehnert B.E. Alpha particles initiate biological production of superoxide anions and hydrogen peroxide in human cells. Cancer Res 57 (1997) 3963-3971
71. Verdier-Sevrain S., Yaar M., Cantatore J., Traish A., and Gilchrest B.A. Estradiol induces proliferation of keratinocytes via a receptor mediated mechanism. FASEB J 18 (2004) 1252-1254
72. Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M.S., Timmers C., Hejna J., et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 7 (2001) 249-262
73. Pichierri P., and Rosselli F. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO J 23 (2004) 1178-1187
74. Chakraborty S., and Massey V. Reaction of reduced flavins and flavoproteins with diphenyliodonium chloride. J Biol Chem 277 (2002) 41507-41516
75. Cross A.R., and Jones O.T. The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labelling of a component polypeptide of the oxidase. Biochem J 237 (1986) 111-116
76. Xie S., Wang Q., Wu H., Cogswell J., Lu L., Jhanwar-Uniyal M., et al. Reactive oxygen species-induced phosphorylation of p53 on serine 20 is mediated in part by polo-like kinase-3. J Biol Chem 276 (2001) 36194-36199
77. Shackelford R.E., Innes C.L., Sieber S.O., Heinloth A.N., Leadon S.A., and Paules R.S. The Ataxia telangiectasia gene product is required for oxidative stress-induced G1 and G2 checkpoint function in human fibroblasts. J Biol Chem 276 (2001) 21951-21959
78. Takao N., Li Y., and Yamamoto K. Protective roles for ATM in cellular response to oxidative stress. FEBS Lett 472 (2000) 133-136
79. Kinscherf R., Deigner H.P., Usinger C., Pill J., Wagner M., Kamencic H., et al. Induction of mitochondrial manganese superoxide dismutase in macrophages by oxidized LDL: its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits. FASEB J 11 (1997) 1317-1328
80. Rotman G., and Shiloh Y. The ATM gene and protein: possible roles in genome surveillance, checkpoint controls and cellular defence against oxidative stress. Cancer Surv 29 (1997) 285-304
81. 2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication. Biochem J 332 Pt 1 (1998) 43-50
82. Dumont P., Burton M., Chen Q.M., Gonos E.S., Frippiat C., Mazarati J.B., et al. Induction of replicative senescence biomarkers by sublethal oxidative stresses in normal human fibroblast. Free Radic Biol Med 28 (2000) 361-373
83. Reichelt J., and Schachtschabel D.O. Energetic stress induces premature aging of diploid human fibroblasts (Wi-38) in vitro. Arch Gerontol Geriatr 32 (2001) 219-231
84. Arad S., Konnikov N., Goukassian D.A., and Gilchrest B.A. T-oligos augment UV-induced protective responses in human skin. FASEB J 20 (2006) 1895-1897
85. de Toledo S.M., Asaad N., Venkatachalam P., Li L., Howell R.W., Spitz D.R., et al. Adaptive responses to low-dose/low-dose-rate gamma rays in normal human fibroblasts: the role of growth architecture and oxidative metabolism. Radiat Res 166 (2006) 849-857
86. Smith D.M., and Raaphorst G.P. Adaptive responses in human glioma cells assessed by clonogenic survival and DNA strand break analysis. Int J Radiat Biol 79 (2003) 333-339
87. Xu Y. DNA damage: a trigger of innate immunity but a requirement for adaptive immune homeostasis. Nat Rev 6 (2006) 261-270
88. Jeeves W.P., and Rainbow A.J. Gamma-ray-enhanced reactivation of irradiated adenovirus in Xeroderma pigmentosum and Cockayne syndrome fibroblasts. Radiat Res 94 (1983) 480-498
89. Jeeves W.P., and Rainbow A.J. U.V. enhanced reactivation of U.V.-and gamma-irradiated adenovirus in normal human fibroblasts. Int J Radiat Biol Relat Stud Phys Chem Med 43 (1983) 599-623
90. Gilchrest BA, Eller MS. The tale of the telomere: implications for prevention and treatment of skin cancers J Invest Dermatol. Symposium proceedings/the Society for Investigative Dermatology, Inc. 2005;10:124-30.
91. Preston R.J. Radiation biology: concepts for radiation protection. Health Phys 88 (2005) 545-556
92. Macip S., Igarashi M., Fang L., Chen A., Pan Z.Q., Lee S.W., et al. Inhibition of p21-mediated ROS accumulation can rescue p21-induced senescence. EMBO J 21 (2002) 2180-2188
93. Goukassian D.A., Bagheri S., el-Keeb L., Eller M.S., and Gilchrest B.A. DNA oligonucleotide treatment corrects the age-associated decline in DNA repair capacity. FASEB J 16 (2002) 754-756
94. Adams M.M., and Carpenter P.B. Tying the loose ends together in DNA double strand break repair with 53BP1. Cell Div 1 (2006) 19
95. Bargonetti J., and Manfredi J.J. Multiple roles of the tumor suppressor p53. Curr Opin Oncol 14 (2002) 86-91
96. Giono L.E., and Manfredi J.J. The p53 tumor suppressor participates in multiple cell cycle checkpoints. J Cell Physiol 209 (2006) 13-20
97. Gomez-Lazaro M., Fernandez-Gomez F.J., and Jordan J. p53: twenty five years understanding the mechanism of genome protection. J Physiol Biochem 60 (2004) 287-307
98. Houtgraaf J.H., Versmissen J., and van der Giessen W.J. A concise review of DNA damage checkpoints and repair in mammalian cells. Cardiovasc Revasc Med 7 (2006) 165-172
99. Livneh Z. Keeping mammalian mutation load in check: regulation of the activity of error-prone DNA polymerases by p53 and p21. Cell Cycle (Georgetown Tex) 5 (2006) 1918-1922
100. Loffler H., Lukas J., Bartek J., and Kramer A. Structure meets function-centrosomes, genome maintenance and the DNA damage response. Exp Cell Res 312 (2006) 2633-2640
101. Lukas J., Bohr V.A., and Halazonetis T.D. Cellular responses to DNA damage: current state of the field and review of the 52nd Benzon Symposium. DNA Repair 5 (2006) 591-601
102. Vousden K.H. Activation of the p53 tumor suppressor protein. Biochim Biophys Acta 1602 (2002) 47-59
103. Hoglund P. DNA damage and tumor surveillance: one trigger for two pathways. Sci STKE 2006 (2006) pe2
104. Roos W.P., and Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med 12 (2006) 440-450
105. Yee K.S., and Vousden K.H. Complicating the complexity of p53. Carcinogenesis 26 (2005) 1317-1322
106. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120 (2005) 513-522
107. 2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1. J Biol Chem 270 (1995) 30334-30338
108. Meier B., Cross A.R., Hancock J.T., Kaup F.J., and Jones O.T. Identification of a superoxide-generating NADPH oxidase system in human fibroblasts. Biochem J 275 Pt 1 (1991) 241-245
109. Balaban R.S., Nemoto S., and Finkel T. Mitochondria, oxidants, and aging. Cell 120 (2005) 483-495
110. Catalano A., Rodilossi S., Caprari P., Coppola V., and Procopio A. 5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation. EMBO J 24 (2005) 170-179
111. Forman H.J., and Torres M. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med 166 (2002) S4-8
112. Arad S., Zattra E., Hebert J., Epstein Jr. E.H., Goukassian D.A., and Gilchrest B.A. Topical thymidine dinucleotide treatment reduces development of ultraviolet-induced basal cell carcinoma in Ptch-1 ± mice. Am J Pathol 172 (2008) 1248-1255
113. Goukassian D.A., Helms E., van Steeg H., van Oostrom C., Bhawan J., and Gilchrest B.A. Topical DNA oligonucleotide therapy reduces UV-induced mutations and photocarcinogenesis in hairless mice. Proc Natl Acad Sci USA 101 (2004) 3933-3938
114. Holland P.C., Clark M.G., Bloxham D.P., and Lardy H.A. Mechanism of action of the hypoglycemic agent diphenyleneiodonium. J Biol Chem 248 (1973) 6050-6056
115. Majander A., Finel M., and Wikstrom M. Diphenyleneiodonium inhibits reduction of iron-sulfur clusters in the mitochondrial NADH-ubiquinone oxidoreductase (Complex I). J Biol Chem 269 (1994) 21037-21042